Response to: 'Cannabis use before safety sensitive work: What delay is prudent?'

Affiliations

• ¹ The University of Sydney, Lambert Initiative for Cannabinoid Therapeutics, Sydney, New South Wales, Australia; The University of Sydney, Brain and Mind Centre, Sydney, New South Wales, Australia; The University of Sydney, Faculty of Science, School of Psychology, Sydney, New South Wales, Australia. Electronic address: danielle.mccartney@sydney.edu.au.
• ² Centre for Human Psychopharmacology, Swinburne University of Technology, Melbourne, Victoria, Australia.
• ³ Menzies Health Institute Queensland and School of Health Sciences and Social Work, Griffith University, Gold Coast, Queensland, Australia.
• ⁴ The University of Sydney, Lambert Initiative for Cannabinoid Therapeutics, Sydney, New South Wales, Australia; The University of Sydney, Brain and Mind Centre, Sydney, New South Wales, Australia; The University of Sydney, Faculty of Science, School of Psychology, Sydney, New South Wales, Australia.